NANOCOMPOSIX, INC. — Department of Health and Human Services SBIR Phase I: ODCDC

NANOCOMPOSIX, INC. — SBIR Phase I award from Department of Health and Human Services.

Amount
$150,000
Agency
Department of Health and Human Services · Centers for Disease Control and Prevention
Program / Phase
SBIR · Phase I
Topic
ODCDC
NAICS
Place of performance
CA
Period

Description

A rapid diagnositic test that can simultaneously detect loiasis onchocerciasis and lymphatic filariasis is of utility both for mapping the prevalence of disease in support of mass drug administration programs and to allow for treatment decisions to be made at the point of care In this proposal we aim to generate a lateral flow based rapid diagnostic test that detects the presence or absence of circulating antibodies to filarial proteins vvhich are validated indications of exposure to L loa volvulus and W bancrofti The lateral flow format allows for a cheap rapid test suitable for low resource environments The assay utilizes novel ultrahigh contrast nanoparticle probes to give a readout in low abundance samples and is configured to allow for a smart phone reado t enabling GPS and other identifying information to be captured in the cloud